AGIO

Agios Pharmaceuticals INC

+$418.4M

Net Activity

Institutions Holding

233

Popularity Rank

#2538

Avg Weight

0.20%

Total Value

$2.2B

Ownership Trend

233 institutions currently hold AGIO, with 110 net buyers and 122 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

122

Net Buying Institutions

110

Key Holders

View all 233 holding institutions

Quarterly Activity

Recent Activity

+$1.3B

Total Buy Value

$893.2M

Total Sell Value

New buy29
Trim84
Add81
Sold out38

110

Net Buyers

122

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

1

Filings (90d)

$151K

Total Est. Value

4K shares

Planned Shares

Last Filed 2026-07-01
FilerFiling DateEst. Value
Gheuens Sarah2026-07-01$151K

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding AGIOS PHARMACEUTICALS INC (AGIO)?
Major stakeholders currently include Armistice Capital, LLC ($200.1M), BlackRock, Inc. ($194.7M), Farallon Capital Management LLC ($192.3M). Based on the latest 13F filings, there are a total of 233 tracked investment funds and institutions maintaining positions in AGIO.
What is the overall institutional sentiment toward AGIO recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $418.4M, driven by 110 managers accumulating shares while 122 reduced their exposure.
Which institutions have been selling or reducing their AGIO positions?
In the latest period, 84 funds trimmed their holdings, and 38 managers completely exited their positions. The aggregate reported sell value was $893.2M.
Are there any notable investors adding AGIO to their portfolios?
Yes, buying activity remains notable. 29 institutions opened new positions in {ticker}, and 81 existing holders added to their shares. The total reported buy value for the quarter amounted to $1.3B.

Related Stocks